Organon (OGN) Income towards Parent Company (2020 - 2026)

Organon (OGN) posted quarterly Income towards Parent Company of $146.0 million for Q1 2026, up 67.82% year-over-year from $87.0 million in Q1 2025, and up 171.22% on a QoQ basis from -$205.0 million in Q4 2025.

Organon (OGN) Income towards Parent Company (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Income towards Parent Company for 6 consecutive years, with $146.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 67.82% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $246.0 million (down 67.2% YoY), while the FY2025 annual figure was $187.0 million, down 78.36% from the prior year.
  • Income towards Parent Company came in at $146.0 million for Q1 2026 at Organon, up from -$205.0 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $546.0 million in Q4 2023, with the low at -$205.0 million in Q4 2025.
  • Average Income towards Parent Company over 4 years is $170.8 million, with a median of $160.0 million recorded in 2025.
  • Across the five-year window, Income towards Parent Company jumped 518.97% in 2024 and slumped 288.07% in 2025, its largest moves.
  • Year by year, Income towards Parent Company stood at $546.0 million in 2023, then sank by 80.04% to $109.0 million in 2024, then plunged by 288.07% to -$205.0 million in 2025, then jumped by 171.22% to $146.0 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $146.0 million, -$205.0 million, and $160.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 146.00 Mn
Dec 31, 2025 -205.00 Mn
Sep 30, 2025 160.00 Mn
Jun 30, 2025 145.00 Mn
Mar 31, 2025 87.00 Mn
Dec 31, 2024 109.00 Mn
Sep 30, 2024 359.00 Mn
Jun 30, 2024 195.00 Mn
Mar 31, 2024 201.00 Mn
Dec 31, 2023 546.00 Mn
Sep 30, 2023 58.00 Mn
Jun 30, 2023 242.00 Mn
Mar 31, 2023 177.00 Mn
Jun 30, 2021 -4.00 Mn
Mar 31, 2021 4.00 Mn
Dec 31, 2020 -8.00 Mn
Sep 30, 2020 -13.00 Mn
Jun 30, 2020 -44.00 Mn
Mar 31, 2020 -31.00 Mn